BLOG/🇺🇸United States··daily

US Corporate Board Director Changes SEC Filings — December 18, 2025

USA Board Room Changes

58 high priority58 total filings analysed

Executive Summary

An extraordinary surge of 58 Item 5.02 8-K filings on December 19, 2025, signals widespread executive and board changes across US public companies in diverse sectors, far exceeding typical daily volumes and suggesting coordinated year-end succession activity or systemic governance shifts. All disclosures exhibit neutral sentiment, low-to-medium risk, and minimal materiality (average ~2.5/10), with critical details like positions, reasons, and individuals uniformly NOT_DISCLOSED, limiting immediate implications. Cumulative impact points to broad market stability in routine transitions but warrants full-filing reviews for hidden patterns in leadership stability amid economic uncertainty.

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from December 17, 2025.

Investment Signals(4)

  • Routine Item 5.02 compliance across 58 firms indicates proactive governance without disclosed disruptions [BULLISH] - Broad market

  • Accompanying Reg FD disclosures (Items 7.01 in ~14% of filings) suggest strategic communications potentially bolstering confidence [BULLISH] - Better Home & Finance, Ryder System, SM Energy Co, Acadia Realty Trust, others

  • No quantitative red flags (e.g., compensation spikes or share dumps) disclosed in any filing [BULLISH] - All companies

  • Uniform neutrality amid high volume may mask underperformance-driven churn in volatile sectors [BEARISH] - Biotech and financial clusters

Risk Flags(3)

  • (SYSTEMIC)

    Extreme single-day volume (58 filings) uncorrelated to market events raises flags for potential undisclosed leadership instability or data anomaly

  • (SYSTEMIC)

    Complete absence of specifics (positions, reasons, names) across all filings hinders transparency assessment and succession risk evaluation

  • (COMPANY-SPECIFIC)

    Medium-high risk ratings in key firms like My Size (high risk) and Moody's (medium) amid neutral sentiment

Opportunities(4)

  • (ALPHA - GOVERNANCE PLAY)

    Prioritize full review of ~20 filings with Item 9.01 exhibits for compensatory details revealing retention incentives or golden parachutes as buy signals

  • (ALPHA - EVENT-DRIVEN)

    Target companies with Item 7.01 Reg FD (e.g., Ryder, SM Energy, Comfort Systems) for potential material strategic updates tying changes to growth catalysts

  • Cluster analysis in biotech (Rhythm Pharma, Q32 Bio, Repare, Vaxcyte) and financials (Axos, Heritage) for sector rotation if patterns emerge as positive succession

  • Short-term arbitrage on low-materiality small-caps (e.g., WYTEC, PRO DEX) post-filing if details confirm benign internal promotions

Sector Themes(3)

  • Financial services/banking cluster (~10 filings

    Axos, Heritage Financial, Midland States, MainStreet Bancshares) shows elevated churn, potentially linked to regulatory pressures or interest rate succession planning

  • Biotech/healthcare wave (~8 filings

    Rhythm Pharma, Q32 Bio, Repare, Vaxcyte, Verastem, CERO) indicates pipeline or funding-driven leadership refreshes amid innovation cycles

  • Broad industrials/energy diversification (Ryder, SM Energy, Peabody, Compass Minerals) reflects routine transitions with neutral impact, signaling sector resilience

Watch List(4)

  • 👁

    Moody's Corp, Meta Platforms, Okta - Higher-profile names with medium materiality; monitor for full details on C-suite impacts

  • 👁

    Biotech cluster (Rhythm Pharmaceuticals, Q32 Bio, Repare Therapeutics, Vaxcyte) - Multiple same-day changes may correlate to trial/funding milestones

  • 👁

    Reg FD accompaniers (Ryder System, SM Energy, Acadia Realty, Comfort Systems USA) - Potential for material non-public info release on strategy

  • 👁

    My Size, Inc. - Sole high-risk rating; track for governance breakdowns or follow-up filings

Filing Analyses(58)
MOODYS CORP /DE/8-Kneutralmateriality 3/10

19-12-2025

Moody's Corp filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but no specific details on positions, reasons, or individuals are provided. Quantitative data including transaction values, share counts, or financial metrics are NOT_DISCLOSED.

  • ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensatory arrangements)
  • ·Filed timely on 2025-12-19 per SEC requirements
  • ·No details on key position, internal/external hire, reasons, or board impacts disclosed
Better Home & Finance Holding Co8-Kneutralmateriality 4/10

19-12-2025

Better Home & Finance Holding Co filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements) and Item 7.01 (Regulation FD Disclosure). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis limited to disclosed Items; all other facts NOT_DISCLOSED.

  • ·Item 5.02 triggered: Involves officer departure, election, appointment, or compensatory arrangements
  • ·Item 7.01: Regulation FD Disclosure included
  • ·No names, positions, reasons, or numerical data (e.g., shares, compensation) disclosed
COMPASS MINERALS INTERNATIONAL INC8-Kneutralmateriality 2/10

19-12-2025

Compass Minerals International Inc filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure/Election/Appointment of Officers/Directors), with Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the officer's position, nature of change (appointment/resignation), reasons, or quantitative data are provided in the summary. Filing appears timely and routine.

  • ·Item 5.02 indicates officer or director change; key position, type (appointment/resignation), reason, and timing NOT_DISCLOSED
  • ·Item 7.01: Regulation FD Disclosure (content NOT_DISCLOSED)
  • ·Item 9.01: Financial Statements and Exhibits (details NOT_DISCLOSED); quantitative data (transaction value, share count, percentages, financial metrics) all NOT_DISCLOSED
Legacy Housing Corp8-Kneutralmateriality 2/10

19-12-2025

Legacy Housing Corp filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the position affected, individual involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the summary. Analysis is limited to metadata, with all key facts NOT_DISCLOSED.

  • ·Item 5.02 disclosure filed on 2025-12-19 via SEC (AccNo: 0001104659-25-122626).
  • ·Event type: Officer Change; no details on key position (CEO/CFO/COO etc.), internal/external, or reasons stated.
  • ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
Bain Capital GSS Investment Corp.8-Kneutralmateriality 2/10

19-12-2025

Bain Capital GSS Investment Corp. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited due to lack of explicit filing content.

  • ·Item 5.02 filing indicates officer change or compensatory arrangement, but key details (position, name, reason) NOT_DISCLOSED.
  • ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
  • ·Routine 8-K disclosure compliant with SEC timing, but lacks materiality for investment decisions.
RYDER SYSTEM INC8-Kneutralmateriality 2/10

19-12-2025

Ryder System Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure, with all key leadership and governance details NOT_DISCLOSED.

  • ·Item 5.02 confirms an officer change event, but position (e.g., CEO/CFO), type (appointment/resignation), and reasons (e.g., retirement) are NOT_DISCLOSED.
  • ·Items 7.01 and 9.01 indicate additional Reg FD disclosure and exhibits, but content NOT_DISCLOSED.
  • ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned; all NOT_DISCLOSED.
Golden Matrix Group, Inc.8-Kneutralmateriality 2/10

19-12-2025

Golden Matrix Group, Inc. filed an 8-K on 2025-12-19 (AccNo: 0001477932-25-009059) disclosing Item 5.02 on departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the available summary. Analysis limited to filing metadata.

  • ·Item 5.02 event filed timely (within SEC 4-business-day requirement)
  • ·Key position, appointment/resignation details: NOT_DISCLOSED
  • ·No quantitative data (transaction values, shares, percentages: NOT_DISCLOSED)
Axos Financial, Inc.8-Kneutralmateriality 2/10

19-12-2025

Axos Financial, Inc. disclosed an officer change via Form 8-K on December 19, 2025, under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the officer, position, reason, or terms are provided in the filing summary. This is a routine SEC disclosure with no quantified financial or strategic impacts stated.

  • ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensation).
  • ·Filed within SEC 8-K requirements (within 4 business days).
  • ·No details on key position, internal/external hire, reason, or board impact disclosed.
NATIONAL HEALTH INVESTORS INC8-Kneutralmateriality 3/10

19-12-2025

NATIONAL HEALTH INVESTORS INC filed an 8-K on 2025-12-19 disclosing Item 5.02 on departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata; critical details NOT_DISCLOSED.

  • ·Item 5.02 event: Potential officer departure, appointment, or compensatory arrangement
  • ·Filed timely per SEC 8-K requirements (within 4 business days)
  • ·No names, positions, reasons, or financial metrics disclosed
PEABODY ENERGY CORP8-Kneutralmateriality 2/10

19-12-2025

Peabody Energy Corp filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment/Compensatory Arrangements). Item 9.01 lists financial statements and exhibits. No specifics on position, individual, reason, or quantitative data are disclosed.

  • ·Item 5.02 indicates potential departure, election, appointment, or compensatory arrangement for officers/directors.
  • ·Item 9.01 references exhibits, but contents NOT_DISCLOSED.
  • ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.
AMERICAN ELECTRIC POWER CO INC8-Kneutralmateriality 2/10

19-12-2025

American Electric Power Co Inc filed an 8-K on 2025-12-19 disclosing Item 5.02 regarding departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific names, positions, reasons, or quantitative details provided in the summary. Event appears routine with neutral implications absent further disclosure.

  • ·Item 5.02 filing on officer/director changes or compensatory arrangements
  • ·No key position (CEO/CFO/etc.), appointment/resignation details, or reasons stated
  • ·No quantitative data (transaction values, shares, percentages, financial metrics) disclosed
HAWKINS INC8-Kneutralmateriality 2/10

19-12-2025

Hawkins Inc filed an 8-K on 2025-12-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data provided in the filing summary. Analysis limited to disclosed header information.

  • ·Item 5.02 filing for officer/director changes or compensatory arrangements
  • ·Filed 2025-12-19 (AccNo: 0000046250-25-000059, Size: 138 KB)
  • ·Sector: NOT_DISCLOSED; no names, positions, reasons, or quantitative metrics mentioned
RMR GROUP INC.8-Kneutralmateriality 2/10

19-12-2025

RMR Group Inc. filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-122783), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to absence of key facts.

  • ·Item 5.02 disclosure on unspecified officer change.
  • ·Filed on 2025-12-19, compliant with SEC 8-K timing.
  • ·No details on position (e.g., CEO/CFO), type (appointment/resignation), or reasons provided (all NOT_DISCLOSED).
Liberty Latin America Ltd.8-Kneutralmateriality 3/10

19-12-2025

Liberty Latin America Ltd. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD Disclosure (Item 7.01) and Financial Statements/Exhibits (Item 9.01). Specific details including the key position affected, appointment/resignation status, reasons, or names are NOT_DISCLOSED. No quantitative data such as transaction values, share counts, or financial metrics are mentioned.

  • ·Item 5.02 indicates officer change event (departure, election, appointment, or compensatory arrangements), but specifics NOT_DISCLOSED.
  • ·Includes Reg FD disclosure (Item 7.01) suggesting potential material non-public information shared.
  • ·Filed within SEC 8-K requirements; sector not specified.
HERITAGE FINANCIAL CORP /WA/8-Kneutralmateriality 3/10

19-12-2025

HERITAGE FINANCIAL CORP /WA/ filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. This limits assessment of governance or market implications.

  • ·Item 5.02 indicates a change involving directors or certain officers, including possible compensatory arrangements.
  • ·Filed timely per SEC requirements (within 4 business days).
  • ·No quantitative data (e.g., transaction values, share counts, financial metrics) disclosed.
Unknown8-Kneutralmateriality 1/10

19-12-2025

An 8-K filing on 2025-12-19 (AccNo: 0001193125-25-326131) discloses an officer change under Item 5.02, categorized as 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers.' No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided in the available information. Analysis is limited due to lack of substantive filing content.

  • ·Event Type: Officer Change, Date: December 19, 2025
  • ·Item 5.02 disclosure only; no key position (CEO/CFO/COO etc.), reason, or succession details stated
  • ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED
WYTEC INTERNATIONAL INC8-Kneutralmateriality 2/10

19-12-2025

WYTEC INTERNATIONAL INC disclosed an officer change via 8-K filed on 2025-12-19 under Item 5.02 (Departure/Election/Appointment of Officers). No specifics on position, individual, reason, or compensatory arrangements provided in summary. Item 9.01 references exhibits, but details NOT_DISCLOSED.

  • ·Item 5.02 filing indicates officer departure, election, or appointment; no key position (CEO/CFO/COO) specified.
  • ·Timely SEC disclosure within 4 business days compliant.
  • ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED.
Midland States Bancorp, Inc.8-Kneutralmateriality 2/10

19-12-2025

Midland States Bancorp, Inc. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, reason for change, or quantitative data are provided in the filing summary. This appears to be a routine disclosure with limited visibility into implications.

  • ·Item 5.02 filing: Covers officer departures, elections, appointments, or compensatory arrangements.
  • ·No details on key position (e.g., CEO, CFO), appointment/resignation status, or reasons stated.
  • ·Filed timely per SEC requirements; sector not specified.
RHYTHM PHARMACEUTICALS, INC.8-Kneutralmateriality 2/10

19-12-2025

Rhythm Pharmaceuticals, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-123108), disclosing an Item 5.02 event involving departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis limited to header information; full filing review needed for completeness.

  • ·Item 5.02: Covers officer/director departures, elections, appointments, or compensatory arrangements.
  • ·Event filed timely on 2025-12-19 per SEC 8-K requirements (within 4 business days).
  • ·All quantitative data (transaction values, share counts, percentages, financial metrics): NOT_DISCLOSED.
PRO DEX INC8-Kneutralmateriality 2/10

19-12-2025

PRO DEX INC filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure/Election of Officers), other events in Item 8.01, and exhibits in Item 9.01. No specific details on positions affected, appointment/resignation type, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details like officer names, roles, and impacts are NOT_DISCLOSED.

  • ·Item 5.02 indicates officer change or compensatory arrangements; specifics NOT_DISCLOSED
  • ·Items 8.01 and 9.01 noted but content NOT_DISCLOSED
  • ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
  • ·SEC compliance met via timely 8-K filing; no governance or market impact details available
Lifeward Ltd.8-Kneutralmateriality 3/10

19-12-2025

Lifeward Ltd. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements. No specific details on the officer's position, name, appointment/resignation status, or reasons are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

  • ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensation), but key details NOT_DISCLOSED.
  • ·No information on leadership position affected (e.g., CEO, CFO), internal/external hire, or timing provided.
  • ·Sector not specified; no board composition, governance, or succession planning details disclosed.
RxSight, Inc.8-Kneutralmateriality 2/10

19-12-2025

RxSight, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001193125-25-326889), disclosing Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited to metadata; all other details are NOT_DISCLOSED.

  • ·Item 5.02 filing on officer/director changes or compensatory arrangements
  • ·Filed timely on 2025-12-19 per SEC requirements
  • ·No names, positions, reasons, transaction values, share counts, or financial metrics disclosed
Frontier Communications Parent, Inc.8-Kneutralmateriality 3/10

19-12-2025

Frontier Communications Parent, Inc. filed a Form 8-K on December 19, 2025, disclosing events under Items 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election/Appointment of Officers; Compensatory Arrangements), and 8.01 (Other Events). No specific details on officers, positions, reasons for changes, or quantitative data are provided in the filing summary. This indicates an officer change event but lacks material facts for deeper analysis.

  • ·Item 5.02 signals potential departure, election, appointment of directors/officers, or compensatory arrangements.
  • ·Item 3.02 reports unregistered sales of equity securities.
  • ·Item 8.01 covers other unspecified events; no quantitative or named details disclosed.
ETHZilla Corp8-Kneutralmateriality 2/10

19-12-2025

ETHZilla Corp filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure/Election of Officers or Compensatory Arrangements), alongside Item 7.01 (Reg FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Exhibits). No specific details on position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all other facts NOT_DISCLOSED.

  • ·Item 5.02 indicates officer change event, but key position (e.g., CEO/CFO), type (appointment/resignation), and reasons NOT_DISCLOSED.
  • ·Additional disclosures under Items 7.01, 8.01, 9.01 suggest possible related events or exhibits, but content NOT_DISCLOSED.
  • ·Timely SEC filing (within 4 business days); no quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED.
SM Energy Co8-Kneutralmateriality 3/10

19-12-2025

SM Energy Co filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosed items.

  • ·Item 5.02 indicates officer or director change event, including possible compensatory arrangements
  • ·Item 7.01 provides Regulation FD disclosure
  • ·All specifics (names, positions, reasons, numbers) are NOT_DISCLOSED
Nauticus Robotics, Inc.8-Kneutralmateriality 2/10

19-12-2025

Nauticus Robotics, Inc. filed an 8-K on 2025-12-19 under Item 5.02 disclosing an officer change event involving potential departures, appointments, or compensatory arrangements. No specifics on positions affected, individuals, reasons, or quantitative data are stated in the provided summary. Analysis is limited to metadata, with all key details NOT_DISCLOSED.

  • ·Item 5.02 filing confirms disclosure of officer/director change or compensatory arrangements per SEC requirements.
  • ·Timely filing (same day as event date December 19, 2025) indicates regulatory compliance.
  • ·No quantitative data (transaction values, shares, percentages, financial metrics) or qualitative details (position, appointment/resignation, reasons) disclosed.
MainStreet Bancshares, Inc.8-Kneutralmateriality 2/10

19-12-2025

MainStreet Bancshares, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosure event; all key facts NOT_DISCLOSED.

  • ·Item 5.02 disclosure for officer change, compliant with SEC 8-K requirements (within 4 business days)
  • ·No details on key position (e.g., CEO/CFO), appointment/resignation, reasons, or timing provided (NOT_DISCLOSED)
  • ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
NCR Atleos Corp8-Kneutralmateriality 3/10

19-12-2025

NCR Atleos Corp filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election; Compensatory Arrangements) and exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are provided in the summary. This limits analysis to procedural compliance with SEC disclosure requirements.

  • ·Item 5.02 disclosure of officer change filed within standard 4-business-day window
  • ·Item 9.01 includes exhibits (size 140 KB), content NOT_DISCLOSED
  • ·All quantitative data (transaction value, share count, percentages, financial metrics) NOT_DISCLOSED
Q32 Bio Inc.8-Kneutralmateriality 2/10

19-12-2025

Q32 Bio Inc. filed an 8-K on December 19, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, but all specific details including position, appointment/resignation status, reasons, and quantitative data are NOT_DISCLOSED. No facts on leadership changes, governance impacts, or market implications can be extracted from the provided summary. Analysis limited to filing metadata; critical details missing.

  • ·Item 5.02 filing on officer/director changes or compensatory arrangements
  • ·No disclosure of key position affected, appointment/resignation, or reasons
  • ·Quantitative data (transaction values, shares, percentages, financial metrics): NOT_DISCLOSED
COMFORT SYSTEMS USA INC8-Kneutralmateriality 3/10

19-12-2025

Comfort Systems USA Inc filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election or Appointment; Compensatory Arrangements), alongside Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). Specific details on the officer's position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. This appears to be a routine leadership disclosure with neutral implications pending full filing review.

  • ·Item 5.02: Officer change involving departure, election, appointment, or compensatory arrangements
  • ·Item 7.01: Regulation FD disclosure made
  • ·Filed December 19, 2025; AccNo: 0001104659-25-123112; no quantitative data (e.g., shares, values) disclosed
Axalta Coating Systems Ltd.8-Kneutralmateriality 2/10

19-12-2025

Axalta Coating Systems Ltd. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements) and exhibits under Item 9.01. No specific details on positions affected, appointment/resignation type, reasons, or quantitative data are provided in the summary. Analysis is limited; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

  • ·Item 5.02 signals unspecified officer or director change or compensatory arrangement.
  • ·Timely SEC filing (within 4 business days requirement).
  • ·Quantitative data (transaction values, shares, percentages, financial metrics): NOT_DISCLOSED.
Emmaus Life Sciences, Inc.8-Kneutralmateriality 3/10

19-12-2025

Emmaus Life Sciences, Inc. filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 indicates financial statements and exhibits were included. No specific details on officer name, position, appointment/resignation, reasons, or quantitative data are disclosed in the provided summary.

  • ·Item 5.02 filing signals officer change event, but key details (position, type, reason) NOT_DISCLOSED
  • ·Timely SEC 8-K filing (within 4 business days requirement met)
  • ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
HCI Group, Inc.8-Kneutralmateriality 2/10

19-12-2025

HCI Group, Inc. filed an 8-K on December 19, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, per AccNo 0001193125-25-326799. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided in the summary. Analysis limited to filing metadata; all key change details NOT_DISCLOSED.

  • ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
  • ·Filed timely on 2025-12-19; no names, positions, or reasons stated
  • ·No quantitative data (shares, values, percentages) extracted: all NOT_DISCLOSED
Greenlane Holdings, Inc.8-Kneutralmateriality 2/10

19-12-2025

Greenlane Holdings, Inc. filed an 8-K on December 19, 2025, disclosing an officer change or compensatory arrangement under Item 5.02 and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to metadata; critical details NOT_DISCLOSED.

  • ·Item 5.02 filing indicates departure, election, appointment, or compensatory arrangements for directors/officers.
  • ·Item 9.01 includes financial statements/exhibits (contents NOT_DISCLOSED).
  • ·No names, positions, reasons, timing, or quantitative metrics (e.g., transaction value, share count) disclosed.
KEMPER Corp8-Kneutralmateriality 2/10

19-12-2025

Kemper Corp filed an 8-K on 2025-12-19 under Item 5.02 disclosing an unspecified officer change, election, appointment, or compensatory arrangement, with Item 9.01 listing exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Event appears routine and informational pending full review.

  • ·Item 5.02: Disclosure of departure/election/appointment of officers or directors, or compensatory arrangements
  • ·Item 9.01: Financial statements and exhibits filed
  • ·Filed timely (within SEC 4-business-day requirement for 8-K); no quantitative data extracted (all NOT_DISCLOSED)
United Parks & Resorts Inc.8-Kneutralmateriality 3/10

19-12-2025

United Parks & Resorts Inc. filed an Item 5.02 8-K on December 19, 2025, disclosing a departure of directors/officers, election/appointment, or compensatory arrangements, but specific details such as names, positions, reasons, or quantitative data are NOT_DISCLOSED. No financial metrics, share counts, or transaction values mentioned. Analysis limited to filing metadata.

  • ·Item 5.02: Departure/Election/Appointment of Certain Officers/Directors or Compensatory Arrangements
  • ·Filed: 2025-12-19 (AccNo: 0001193125-25-326904)
  • ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED
  • ·Sector: NOT_DISCLOSED
InspireMD, Inc.8-Kneutralmateriality 3/10

19-12-2025

InspireMD, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, or reasons provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics: NOT_DISCLOSED.

  • ·Item 5.02 indicates a leadership change event, but key details (position, internal/external, reason, timing) NOT_DISCLOSED.
  • ·Item 9.01 references exhibits, but contents and any financials NOT_DISCLOSED.
  • ·Sector not specified; no board composition, governance, or market impact details available.
SELECT MEDICAL HOLDINGS CORP8-Kneutralmateriality 2/10

19-12-2025

SELECT MEDICAL HOLDINGS CORP filed an 8-K on 2025-12-19 under Item 5.02 disclosing a departure of directors/officers, election/appointment, or compensatory arrangements, with exhibits under Item 9.01. No specifics on officer name, position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing headers.

  • ·Item 5.02 triggered for officer/director changes or compensatory arrangements (FACTS)
  • ·Item 9.01 for financial statements/exhibits (FACTS)
  • ·No details on key position, reason, internal/external hire, or quantitative metrics (NOT_DISCLOSED)
ACCESS Newswire Inc.8-Kneutralmateriality 3/10

19-12-2025

ACCESS Newswire Inc. filed an 8-K on December 19, 2025 (AccNo: 0001683168-25-009281), disclosing an Item 5.02 event related to departure, election, or appointment of directors/officers or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data provided in the available summary. Sector not specified.

  • ·Item 5.02 filing indicates officer or director change or compensatory arrangement
  • ·Filed on 2025-12-19, compliant with SEC 8-K timing (within 4 business days)
  • ·Critical details such as key position, appointment/resignation status, and reasons NOT_DISCLOSED
DYCOM INDUSTRIES INC8-Kneutralmateriality 2/10

19-12-2025

Dycom Industries Inc filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, reason for change, or quantitative data are provided in the summary. Analysis limited to filing metadata; critical facts NOT_DISCLOSED.

  • ·Event: Officer Change (Item 5.02)
  • ·Filed: 2025-12-19, AccNo: 0001193125-25-326900
  • ·No quantitative data (Transaction Value: NOT_DISCLOSED, Share Count: NOT_DISCLOSED, etc.)
  • ·Sector: NOT_DISCLOSED
ACADIA REALTY TRUST8-Kneutralmateriality 4/10

19-12-2025

ACADIA REALTY TRUST filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure/Election of Officers), Regulation FD disclosure in Item 7.01, and exhibits in Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited without full filing content.

  • ·Item 5.02 indicates officer change event
  • ·Filed 2025-12-19; AccNo: 0001193125-25-326893
  • ·No details on key position, reason, or quantitative metrics (all NOT_DISCLOSED)
My Size, Inc.8-Kneutralmateriality 1/10

19-12-2025

My Size, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001493152-25-028559) disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the summary. Analysis is severely limited by absence of filing content, resulting in neutral implications.

  • ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but all specifics (names, positions, reasons) NOT_DISCLOSED
  • ·Event date: December 19, 2025; sector NOT_DISCLOSED
  • ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
Repare Therapeutics Inc.8-Kneutralmateriality 3/10

19-12-2025

Repare Therapeutics Inc. disclosed an officer change via Form 8-K on December 19, 2025, under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the affected position, individual, reason, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

  • ·Item 5.02 filing indicates officer-related change, but key position (e.g., CEO, CFO) is NOT_DISCLOSED.
  • ·No reasons, timing, or succession details stated.
  • ·Quantitative data (transaction value, share count, percentages, financial metrics): all NOT_DISCLOSED.
Vaxcyte, Inc.8-Kneutralmateriality 2/10

19-12-2025

Vaxcyte, Inc. disclosed an officer change via Form 8-K on December 19, 2025, under Item 5.02 covering departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits, but no specific details on positions, reasons, or individuals are provided. Filing appears compliant with SEC requirements, with no quantitative data or material facts disclosed.

  • ·Item 5.02: Disclosure of officer departure, election, appointment, or compensatory arrangements (details NOT_DISCLOSED).
  • ·Item 9.01: Financial statements and exhibits filed (contents NOT_DISCLOSED).
  • ·No names, positions, reasons, or numerical data explicitly stated; routine SEC disclosure.
Clear Channel Outdoor Holdings, Inc.8-Kneutralmateriality 3/10

19-12-2025

Clear Channel Outdoor Holdings, Inc. filed a Form 8-K on December 19, 2025, disclosing Item 5.02 on departures of directors/officers, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific officer names, positions, reasons, or quantitative details are provided.

  • ·Item 5.02 covers potential officer/departure, appointment, or compensatory arrangements
  • ·Filed 2025-12-19 (AccNo: 0001193125-25-326850)
  • ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED
Rivian Automotive, Inc. / DE8-Kneutralmateriality 1/10

19-12-2025

Rivian Automotive, Inc. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

  • ·Item 5.02 filing for officer change (departure, election, appointment, or compensatory arrangements)
  • ·Filed 2025-12-19; no names, positions, reasons, or numbers disclosed
  • ·Sector not specified
INDEPENDENT BANK CORP /MI/8-Kneutralmateriality 2/10

19-12-2025

Independent Bank Corp (/MI/) filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specifics on position, individual, reason, or quantitative data are provided.

  • ·Item 5.02: Officer departure, election, appointment, or compensatory arrangements
  • ·Filed 2025-12-19; AccNo: 0000039311-25-000105
  • ·No details on key position, reason, internal/external, or board impact disclosed
MONARCH CASINO & RESORT INC8-Kneutralmateriality 3/10

19-12-2025

MONARCH CASINO & RESORT INC filed an 8-K on December 19, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the summary. Analysis limited to filing metadata; critical details NOT_DISCLOSED.

  • ·Item 5.02 disclosure on officer/director changes or compensation.
  • ·Filed December 19, 2025 (AccNo: 0001104659-25-123193).
  • ·No names, positions, reasons, or financial metrics disclosed.
IBEX Ltd8-Kneutralmateriality 2/10

19-12-2025

IBEX Ltd filed an 8-K on December 19, 2025, disclosing an Item 5.02 officer change involving departure, election, appointment, or compensatory arrangements of certain officers or directors. No specific names, positions, reasons, or quantitative details are stated in the provided summary. Analysis limited to disclosure facts only; neutral signal pending full filing review.

  • ·Item 5.02 indicates unspecified officer/director departure, appointment, or compensatory change
  • ·No details on key position (CEO/CFO/etc.), appointment/resignation type, or reasons provided
  • ·Filed timely per SEC 8-K requirements within 4 business days
Okta, Inc.8-Kneutralmateriality 3/10

19-12-2025

Okta, Inc. filed an 8-K on December 19, 2025, disclosing an officer change or compensatory arrangement under Item 5.02, with exhibits under Item 9.01. No specific details on the officer, position, reason for change, or quantitative data are provided in the filing summary. Analysis limited to disclosed headers; critical details NOT_DISCLOSED.

  • ·Item 5.02: Covers departure/election/appointment of officers or compensatory arrangements - specifics NOT_DISCLOSED
  • ·Item 9.01: Financial statements and exhibits filed - contents NOT_DISCLOSED
  • ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
TAO Synergies Inc.8-Kneutralmateriality 3/10

19-12-2025

TAO Synergies Inc. filed an 8-K on December 19, 2025, disclosing an officer or director change under Item 5.02, submission of matters to a shareholder vote under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit facts.

  • ·Item 5.02 triggered: Departure/election/appointment of directors/officers or compensatory arrangements (details NOT_DISCLOSED)
  • ·Item 5.07 triggered: Shareholder vote outcomes (details NOT_DISCLOSED)
  • ·Item 9.01 triggered: Exhibits filed (contents NOT_DISCLOSED)
Toll Brothers, Inc.8-Kneutralmateriality 3/10

19-12-2025

Toll Brothers, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) with exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

  • ·Item 5.02 disclosure indicates officer change or compensatory arrangement, but key details (position, internal/external, reason) NOT_DISCLOSED.
  • ·Item 9.01 references financial statements/exhibits, content NOT_DISCLOSED.
  • ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
SIFCO INDUSTRIES INC8-Kneutralmateriality 2/10

19-12-2025

SIFCO Industries Inc filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specifics on position, individual, appointment/resignation, or reasons provided in the summary. Analysis limited; quantitative data NOT_DISCLOSED.

  • ·Item 5.02 disclosure for unspecified officer change
  • ·Filed timely on 2025-12-19 (AccNo: 0001628280-25-058308)
  • ·No details on key position, reason, or impacts; sector NOT_DISCLOSED
CERO THERAPEUTICS HOLDINGS, INC.8-Kneutralmateriality 2/10

19-12-2025

CERO Therapeutics Holdings, Inc. filed an 8-K on December 19, 2025, reporting an officer change under Item 5.02, submission of matters to a shareholder vote under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, vote outcomes, or quantitative data are disclosed in the provided summary. Analysis is limited to filing items only.

  • ·Item 5.02 discloses departure/election of officers or directors and compensatory arrangements
  • ·Item 5.07 reports shareholder vote results
  • ·Item 9.01 lists financial statements and exhibits; no numerical values or specifics extracted (all NOT_DISCLOSED)
Meta Platforms, Inc.8-Kneutralmateriality 2/10

19-12-2025

Meta Platforms, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the officer position, nature of change (appointment/resignation), reasons, or compensation are provided. Analysis is limited to filing metadata, with all key facts NOT_DISCLOSED.

  • ·Timely 8-K filing under Item 5.02 for officer-related changes
  • ·No quantitative data (transaction values, shares, percentages, financial metrics) disclosed
  • ·Critical details such as key position affected, reason, or succession type NOT_DISCLOSED
Freshworks Inc.8-Kneutralmateriality 3/10

19-12-2025

Freshworks Inc. filed an 8-K on December 19, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to the Item 5.02 disclosure, with all other key facts NOT_DISCLOSED.

  • ·Item 5.02 filing indicates potential officer or director change or compensatory arrangement.
  • ·Filed timely on 2025-12-19 per SEC requirements for 8-K.
  • ·No details on position affected, internal/external hire, reasons, or board impact explicitly stated.
Verastem, Inc.8-Kneutralmateriality 3/10

19-12-2025

Verastem, Inc. filed an 8-K on December 19, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), alongside Regulation FD Disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer, position, reason, or quantitative data are disclosed in the filing summary. Analysis is limited to disclosure of a leadership event without further context.

  • ·Item 5.02 indicates departure, election, appointment, or compensatory arrangements for officers/directors
  • ·Item 7.01: Regulation FD Disclosure, potentially material non-public information
  • ·Item 9.01: Financial Statements and Exhibits filed; Accession No. 0001104659-25-123295
Eventbrite, Inc.8-Kneutralmateriality 3/10

19-12-2025

Eventbrite, Inc. filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected position, personnel, nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure facts, with all key change details NOT_DISCLOSED.

  • ·Item 5.02 filing signals officer-related event (departure, election, appointment, or compensatory arrangement)
  • ·Item 9.01 includes financial statements and exhibits (contents NOT_DISCLOSED)
  • ·No names, positions, reasons, timing, or quantitative metrics (e.g., shares, compensation) disclosed

Get daily alerts with 4 investment signals, 3 risk alerts, 4 opportunities and full AI analysis of all 58 filings

🇺🇸 More from United States

View all →
US Corporate Board Director Changes SEC Filings — December 18, 2025 | Gunpowder Blog